Поисковый запрос: (<.>S=ИММУНИТЕТ ПРОТИВООПУХОЛЕВЫЙ<.>) |
Общее количество найденных документов : 167
Показаны документы с 1 по 20
|
|
1.
| Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumo growth and induce antitumor immunity to a murine melanoma in vivo // Cancer Res., 1994. Vol. 54, N 1.-С.182-189
|
2.
| Induction of specific anti-tumour immunity by interferon-'гамма' gene-transferred murine bladder carcinoma MBT-2 // Folia biol.. -Praha, 1994. Vol. 40, N 1-2.-С.49-61
|
3.
| Eggers Arnold E. Non-malignant cells coupled to adjuvants and their use in a method to induce anti-tumor immunity
|
4.
| Smith Doctors can find no gene for immunity to tobacco-caused cancers // Cancer and Genet. Rept., 1993, N Oct..-С.1, 3
|
5.
| Enhancing the recognition of tumour associated antigens // Folia biol.. -Praha, 1994. Vol. 40, N 1-2.-С.74-88
|
6.
| Lumpkin Ellen A. A {5}{1}Cr release assay for the determination of natural killer cell cytotoxicity // J. Nutr. Immunol, 1992. Vol. 1, N 3.-С.63-74
|
7.
| Tumor immunogenicity determines the effect of B7 costimulation on T cell-mediated tumor immunity // J. Exp. Med, 1994. Vol. 179, N 2.-С.523- 532
|
8.
| Systemic administration of rIL-12 induces complete tumor regression and protective immunity: Response is correlated with a striking reversal of suppressed IFN-'гамма' production by anti-tumor T cells // Int. Immunol., 1995. Vol. 7, N 7.-С.1135-1145
|
9.
| Systemic administration of rIL-12 induces complete tumor regression and protective immunity: Response is correlated with a striking reversal of suppressed IFN-'гамма' production by anti-tumor T cells // Int. Immunol., 1995. Vol. 7, N 7.-С.1135-1145
|
10.
| Systemic administration of rIL-12 induces complete tumor regression and protective immunity: Response is correlated with a striking reversal of suppressed IFN-'гамма' production by anti-tumor T cells // Int. Immunol., 1995. Vol. 7, N 7.-С.1135-1145
|
11.
| Взаимосвязь эстрогенного фона и активности клеточного иммунитета у больных раком эндометрия // Вопр. онкол. помощи на этапе реформир. здравоохр.. -Екатеринбург, 1996.-С.122
|
12.
| B7-1 and interleukin 12 synergistically induce effective antitumor immunity // Cancer Res., 1995. Vol. 55, N 21.-С.4980-4987
|
13.
| Endogenous c-src as a determinant of the tumorigenicity of src oncogenes // Proc. Nat. Acad. Sci. USA, 1996. Vol. 93, N 2.-С.824-827
|
14.
| Antitumor effect of CD40 ligand: Elicitation of local and systemic antitumor responses by IL-12 and B7 // J. Immunol., 1998. Vol. 161, N 4.-С.1901-1907
|
15.
| Manzo G. The cancer process as a type of immunocomplex hypersensibility involving C3b, natural killer cytotoxicity and antibody-dependent cell cytotoxicity: Proposals for tumour immunotherapy and vaccine // Med. Hypotheses, 1998. Vol. 50, N 5.-С.409-413
|
16.
| Antitumor effect of CD40 ligand: Elicitation of local and systemic antitumor responses by IL-12 and B7 // J. Immunol., 1998. Vol. 161, N 4.-С.1901-1907
|
17.
| Antitumor effect of CD40 ligand: Elicitation of local and systemic antitumor responses by IL-12 and B7 // J. Immunol., 1998. Vol. 161, N 4.-С.1901-1907
|
18.
| Manzo G. The cancer process as a type of immunocomplex hypersensibility involving C3b, natural killer cytotoxicity and antibody-dependent cell cytotoxicity: Proposals for tumour immunotherapy and vaccine // Med. Hypotheses, 1998. Vol. 50, N 5.-С.409-413
|
19.
| Manzo G. The cancer process as a type of immunocomplex hypersensibility involving C3b, natural killer cytotoxicity and antibody-dependent cell cytotoxicity: Proposals for tumour immunotherapy and vaccine // Med. Hypotheses, 1998. Vol. 50, N 5.-С.409-413
|
20.
| Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes // Jap. J. Cancer Res., 1998. Vol. 89, N 7.-С.775-782
|
&uf('+1W2226#',v2226), ?>
|
|